Leading Pharmaceutical Marketing Research and Consulting Company Announces Strong Performance in 2010

BLUE BELL, Pa., May 2, 2011 /PRNewswire/ -- Evolution Marketing Research, the next-generation pharmaceutical marketing research and consulting company, announced its 2010 sales revenue of $12,500,000, representing 11% growth since 2009.  

"In what has been a difficult period for the industry over the past several years, we have consistently grown and expanded our capabilities to meet the needs of our clients. This past year we expanded our reach in both the core developed and emerging global markets," Principal Jim Cummings said. "We believe that consistent growth, especially during these times, is a testament to both the professional competence of the organization and the faith of our clients."  

While the company exceeded key financial objectives for 2010, it also reported other significant milestones achieved during the past year:  

• Launch of new methodologies like Minimal Expectations Modeling (MEM(SM)) and Qualitative Pre-Conjoint Simulation (PreSIM(SM));
• Expansion of quantitative capabilities with the introduction of in-house programming enabling the company to manage projects more effectively, thus increasing efficiency and productivity while decreasing costs;
• Developing new global business partnerships with research and fielding firms in both the Developed and Emerging Markets;
• Hiring new professional researchers and support personnel at variety of levels, with total of twenty-five full-time employees (up from eighteen in 2009).

Evolution's founding principals look forward to continued growth over the course of 2011 and into 2012 thanks to expansion within the current client base, as well as bringing quantitative service offerings to a greater percentage of the overall business mix. According to Principal Dr. John Taenzler, in 2011 the company will focus on the development of new relationships in the Biopharma industry.

"While strategic research and consultation will continue to be our primary goal, we will also move towards raising our share of global projects in line with the marketplace's appetite for global growth, especially in the developing world," Taenzler added.  

This strong performance in 2010 continues Evolution's overall annual growing trend since its inception in 2007.

About Evolution Marketing Research, LLC:

Evolution Marketing Research is a medical marketing research firm that provides qualitative and quantitative research, consulting services, project management, advisory board monitoring and other marketing research services to pharmaceutical, biotech and medical device companies all over the world. Company Principals John Taenzler, Ph.D., Jim Cummings, and James Heasley, Ph.D., who are backed by a seasoned team of analysts and researchers, bring their collective experience to bear on pharmaceutical projects at all phases of the product lifecycle, including opportunity and licensing assessments, product crafting in support of phase III clinical trial design, and development of the commercial platform for developmental and in-line products. To learn more, visit http://www.evolved-mr.com or call (866) 486-0873.

Media Contact:

PR PERFECT LLC
Inna Lobanova-Heasley
215-280-4824
[email protected]

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.

SOURCE Evolution Marketing Research, LLC